ATA Update American Thyroid Association (ATA) Satellite Symposium: The 2016 Release of Two ATA Clinical Guidelines: Management of Hyperthyroidism and Thyroid Illness During Pregnancy

Program: Satellite Programs
Thursday, March 31, 2016: 1:00 PM-5:30 PM
Room 156 (BCEC)

Registration is required for this session:
ATA/Endocrine Society Members: $149

Nonmembers: $169

ATA/Endocrine Society In-Training Members: $29

Register now for this exciting program to hear the most recent recommendations from the interdisciplinary international guidelines task forces. ATA Satellite Symposium registration is available as part of the Endocrine Society 2016 Annual Meeting at Please complete the online registration process or click here to complete the Endocrine Society paper registration form.  The ATA satellite program is listed on the top right of page 2 of this form.

2016 ATA Guidelines: Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Chair: Douglas Ross, MD, Massachusetts General Hospital

Numerous studies since the publication of the 2011 guidelines have addressed the diagnosis and management of thyrotoxic patients. The ATA has developed new and updated evidence-based recommendations to guide the clinical assessment and management of patients with hyperthyroidism and other causes of thyrotoxicosis. Task force members will give special focus to:

  • New paradigms for establishing the etiology of thyrotoxicosis
  • Updated evidence for choosing treatment options for hyperthyroidism
  • Expanded coverage of less common causes of thyrotoxicosis

2016 ATA Guidelines: Thyroid Disease During Pregnancy 

Chairs: Elizabeth Pearce, MD, Boston University and Erik Alexander, MD, Brigham and Women’s Hospital.

Thyroid disease is common in pregnant women. The diagnosis and treatment of thyroid dysfunction in pregnancy provides unique challenges. A large amount of new information and evidence grading processes has become available since the 2011 guidelines prompting the ATA to develop new and updated evidence-based recommendations to assist in the clinical management of pregnant patients with thyroid disease. Task force members will give special focus to:

  • New definitions and treatment paradigms for hypothyroidism in pregnancy
  • Treatment of hyperthyroidism in pregnant women
  • Screening for thyroid dysfunction in pregnancy
1:00 PM

Douglas S Ross, MD, Thyroid Unit ACC-730 S, Massachusetts General Hospital, Waban, MA
Disclosure Not Provided: DSR
1:15 PM

David S. Cooper, MD, Division of Endocrinology, Diabetes, and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD
Nothing to Disclose: DSC
1:30 PM

Martin A Walter, MD, University Hospital, Bern, Switzerland
Disclosure Not Provided: MAW
1:45 PM

Julie Ann Sosa, MD, MA, Endocrine Surgery, Duke University, Durham, NC
JAS: Member of the Data Monitoring Committee of the Medullary Thyroid Cancer Registry, funded by Astra Zeneca, NovoNordisk, GlaxoSmithKline, and Eli Lilly., Member of the Data Monitoring Committee of the Medullary Thyroid Cancer Registry.
2:00 PM

Scott A Rivkees, University of Florida, Shands Children's Hospital, Gainesville, FL
Disclosure Not Provided: SAR
2:15 PM

Peter Laurberg, Prof, MDSc, Dept. of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Nothing to Disclose: PL
2:30 PM

Henry B Burch, MD, Endocrinology, Diabetes, and Metabolism, Walter Reed National Military Medical Center, Potomac, MD
Disclosure Not Provided: HBB
2:45 PM

Gregory A Brent, MD, Department of Medicine and Physiology, Veteran Affair Greater Los Angeles Healthcare System and David Geffen School of Medicine at UCLA, Los Angeles, CA
Nothing to Disclose: GAB
3:00 PM

Robin P. Peeters, Internal Medicine, Erasmus Univ Rotterdam, Rotterdam, Netherlands
Disclosure Not Provided: RPP
3:15 PM

Chrysoula Dosiou, Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, CA
Nothing to Disclose: CD
3:30 PM

Peter Laurberg, Prof, MDSc, Dept. of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Nothing to Disclose: PL
3:45 PM

Rosalind S Brown, MD, Division of Endocrinology, Boston Children's Hospital, Boston, MA
Disclosure Not Provided: RSB
4:00 PM

Susan J Mandel, MD, MPH, Perelman School of Medicine, University of Pennsylvania, Ardmore, PA and Herbert Chen, Department of Surgery, University of Alabama, Birmingham, AL
Nothing to Disclose: HC Disclosure Not Provided: SJM
4:15 PM

Erik Karl Alexander, MD, Division of Endocrinology, Thyroid Unit, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
Disclosure Not Provided: EKA
4:30 PM

Elizabeth N Pearce, MD MSC, Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center, Boston, MA
Nothing to Disclose: ENP
See more of: Satellite Programs